Annual Accounts Receivable
$82.00 M
-$7.45 M-8.33%
31 December 2023
Summary:
Organogenesis Holdings annual accounts receivable is currently $82.00 million, with the most recent change of -$7.45 million (-8.33%) on 31 December 2023. During the last 3 years, it has risen by +$25.20 million (+44.35%). ORGO annual accounts receivable is now -8.33% below its all-time high of $89.45 million, reached on 31 December 2022.ORGO Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Accounts Receivable
$101.27 M
-$4.67 M-4.41%
30 September 2024
Summary:
Organogenesis Holdings quarterly accounts receivable is currently $101.27 million, with the most recent change of -$4.67 million (-4.41%) on 30 September 2024. Over the past year, it has increased by +$12.00 million (+13.44%). ORGO quarterly accounts receivable is now -4.41% below its all-time high of $105.94 million, reached on 30 June 2024.ORGO Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ORGO Accounts Receivable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -8.3% | +13.4% |
| 3 y3 years | +44.4% | +35.8% |
| 5 y5 years | +140.6% | +194.5% |
ORGO Accounts Receivable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -8.3% | +44.4% | -4.4% | +35.8% |
| 5 y | 5 years | -8.3% | +140.6% | -4.4% | +209.5% |
| alltime | all time | -8.3% | +191.6% | -4.4% | +260.1% |
Organogenesis Holdings Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $101.27 M(-4.4%) |
| June 2024 | - | $105.94 M(+10.2%) |
| Mar 2024 | - | $96.15 M(+17.3%) |
| Dec 2023 | $82.00 M(-8.3%) | $82.00 M(-8.2%) |
| Sept 2023 | - | $89.28 M(-4.6%) |
| June 2023 | - | $93.61 M(+1.7%) |
| Mar 2023 | - | $92.02 M(+2.9%) |
| Dec 2022 | $89.45 M(+8.5%) | $89.45 M(-3.9%) |
| Sept 2022 | - | $93.11 M(+4.8%) |
| June 2022 | - | $88.82 M(+11.8%) |
| Mar 2022 | - | $79.48 M(-3.6%) |
| Dec 2021 | $82.46 M | $82.46 M(+10.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2021 | - | $74.58 M(-2.8%) |
| June 2021 | - | $76.77 M(+6.6%) |
| Mar 2021 | - | $72.00 M(+26.8%) |
| Dec 2020 | $56.80 M(+44.3%) | $56.80 M(-0.2%) |
| Sept 2020 | - | $56.91 M(+29.3%) |
| June 2020 | - | $44.02 M(+34.5%) |
| Mar 2020 | - | $32.72 M(-16.9%) |
| Dec 2019 | $39.36 M(+15.5%) | $39.36 M(+14.5%) |
| Sept 2019 | - | $34.38 M(+0.7%) |
| June 2019 | - | $34.16 M(+5.1%) |
| Mar 2019 | - | $32.51 M(-4.6%) |
| Dec 2018 | $34.08 M(+21.2%) | $34.08 M(+21.2%) |
| Dec 2017 | $28.12 M | $28.12 M |
FAQ
- What is Organogenesis Holdings annual accounts receivable?
- What is the all time high annual accounts receivable for Organogenesis Holdings?
- What is Organogenesis Holdings annual accounts receivable year-on-year change?
- What is Organogenesis Holdings quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for Organogenesis Holdings?
- What is Organogenesis Holdings quarterly accounts receivable year-on-year change?
What is Organogenesis Holdings annual accounts receivable?
The current annual accounts receivable of ORGO is $82.00 M
What is the all time high annual accounts receivable for Organogenesis Holdings?
Organogenesis Holdings all-time high annual accounts receivable is $89.45 M
What is Organogenesis Holdings annual accounts receivable year-on-year change?
Over the past year, ORGO annual accounts receivable has changed by -$7.45 M (-8.33%)
What is Organogenesis Holdings quarterly accounts receivable?
The current quarterly accounts receivable of ORGO is $101.27 M
What is the all time high quarterly accounts receivable for Organogenesis Holdings?
Organogenesis Holdings all-time high quarterly accounts receivable is $105.94 M
What is Organogenesis Holdings quarterly accounts receivable year-on-year change?
Over the past year, ORGO quarterly accounts receivable has changed by +$12.00 M (+13.44%)